Clare Hague on drug pricing and market access - European Medical Journal

Clare Hague on drug pricing and market access

EMJ GOLD
Season 01: episode 70

GOLD talks to Clare Hague, Senior Director, Haematology Market Access, Europe, the Middle East, and Africa, Janssen. She shares her perspective on the industry’s drug pricing challenges and opportunities, details alternative pricing systems that could improve access in low-to-middle-income countries, and explores the shifting market access landscape within oncology.

Rate this content's potential impact on patient outcomes

Thank you!

Please share some more information on the rating you have given